About Jacob Ørndrup

Jacob Ørndrup is widely recognised in Denmark and abroad as a leading expert in pharmaceutical law and healthcare law, and in R&D agreements and licence agreements. He has advised clients in cases concerning medicinal products, medical devices, biotechnology, food products, cosmetics and chemical products for more than 25 years. Jacob also has extensive experience in intellectual property law and litigation, including infringement cases and preliminary injunction proceedings. Jacob joined Loeven on 1 January 2022. Previously, he worked with Gorrissen Federspiel as an attorney from 1998 and as a partner from 2003 to 2022. He was admitted to the Danish Bar in 1995 and obtained right of audience before the Danish Supreme Court in 2002.